معرفی
Dr. Salvatore Gazze is an affiliated researcher at Swansea University within the Reproductive Biology and Gynecological Oncology (RBGO) research group, part of the Faculty of Medicine, Health and Life Science. He holds a MSc in Pharmaceutical Biotechnology from the University of Bologna and a PhD in Nanoscience from the University of Bristol. His career spans over 19 years, including research roles in Spain and his current focus on applying nanoscience to biomedical challenges.
His research expertise spans nanoscience, biosensors, biogeochemistry, and data analysis. Key areas include developing nanotechnology-based solutions for cancer diagnosis and therapy, such as graphene biosensors for early ovarian cancer detection and selenium nanoparticle studies targeting cancer cell mechanics. He has contributed to interdisciplinary projects like the RISE initiative on exosome clinical utility.
Publications highlight his work on nanoparticle-cell interactions, AFM analysis of extracellular vesicles, and functionalized nanomicelles for drug delivery. Though no formal awards are listed, his contributions to cancer nanomedicine and biomaterials are notable. He collaborates widely, including on soil characterization studies using AFM techniques presented at international conferences such as the 2017 event in Grenoble, France.
Current affiliations include the RBGO group and involvement in grants spanning biomedical and environmental research. His work bridges physics, chemistry, and engineering to address medical challenges, reflecting his broad scientific curiosity.
